Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07569588
Improving Patient Assessment After Acute Kidney Injury (AKI)University Hospitals of Derby and Burton NHS Foundation TrustRecruiting
NCT07569588Recruiting
—
Improving Patient Assessment After Acute Kidney Injury (AKI)University Hospitals of D...
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07570498
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07570498Completed
Not Applicable
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of...
NCT07570576
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hong KongNot Yet RecruitingNot Applicable
NCT07570576Not Yet Recruiting
Not Applicable
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hon...
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07570537
TubeClear System Evaluation in Pediatric PatientsChildren's Mercy Hospital Kansas CityNot Yet RecruitingNot Applicable
NCT07570537Not Yet Recruiting
Not Applicable
TubeClear System Evaluation in Pediatric PatientsChildren's Mercy Hospital...
NCT07569484
Effectiveness of Dry Needling in Athletes With Chronic Hamstring StrainCairo UniversityNot Yet RecruitingNot Applicable
NCT07569484Not Yet Recruiting
Not Applicable
Effectiveness of Dry Needling in Athletes With Chronic Hamstring StrainCairo University
NCT07568561
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial HospitalNot Yet Recruiting
NCT07568561Not Yet Recruiting
—
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial Hosp...
NCT07570212
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersChangping LaboratoryRecruitingNot Applicable
NCT07570212Recruiting
Not Applicable
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersChangping Laboratory
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569276
Effects of an Experimental Propolis Gel on Tooth Sensitivity Control and Post-bleaching Color Change: a Randomized Clinical TrialUniversidade Federal do ParaNot Yet RecruitingNot Applicable
NCT07569276Not Yet Recruiting
Not Applicable
Effects of an Experimental Propolis Gel on Tooth Sensitivity Control and Post-bl...Universidade Federal do P...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMShanghai Jiao Tong University School of MedicineNot Yet RecruitingNot Applicable
NCT07570810Not Yet Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD...Shanghai Jiao Tong Univer...
NCT07570355
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acupuncture, Moxibustion and MeridianNot Yet RecruitingNot Applicable
NCT07570355Not Yet Recruiting
Not Applicable
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acu...
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07569211
Simplified HCV Integrated Management Model in Methadone Clinics in UkraineThe Western-Eastern European Partnership Initiative on HIV, Viral Hepatitis and TBCompletedNot Applicable
NCT07569211Completed
Not Applicable
Simplified HCV Integrated Management Model in Methadone Clinics in UkraineThe Western-Eastern Europ...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 22 (10%)